Acrivon Therapeutics, Inc. (ACRV) Corporate Subsidiaries
Acrivon Therapeutics, Inc. (ACRV) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ACRV
CIK: 1781174
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerAsif Khoja
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-07 | 2026-10-05 | FORM 4 | 0000905148-26-004399 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | FORM 4 | 0000905148-26-004065 | View SEC Doc Filr Page |
| 3 | 2026-09-02 | 2026-08-31 | FORM 3 | 0000905148-26-004064 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-25 | FORM 4 | 0000905148-26-003968 | View SEC Doc Filr Page |
| 144 | 2026-08-25 | — | 144 Filing | 0000905148-26-003924 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | FORM 4 | 0000905148-26-003840 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | FORM 4 | 0000905148-26-003839 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | FORM 4 | 0000905148-26-003838 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | FORM 4 | 0000905148-26-003837 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | FORM 4 | 0000905148-26-003836 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001875620-26-000015 | View SEC Doc Filr Page |
| S-8 | 2026-08-12 | — | S-8 | 0001193125-26-347003 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001193125-26-346859 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001193125-26-346819 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-04 | FORM 4 | 0000905148-26-003499 | View SEC Doc Filr Page |
| 4 | 2026-07-23 | 2026-07-21 | FORM 4 | 0000905148-26-003334 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | 4 Filing | 0001231919-26-000686 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003042 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003041 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003035 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003034 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003033 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003024 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-17 | 8-K | 0001193125-26-274410 | View SEC Doc Filr Page |
| 4 | 2026-05-26 | 2026-05-21 | FORM 4 | 0000905148-26-002652 | View SEC Doc Filr Page |